quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:32:19·161d
SECFiling
Cytosorbents Corporation logo

SEC Form 10-Q filed by Cytosorbents Corporation

CTSO· Cytosorbents Corporation
Health Care
Full content unavailable. See the original source below.
Original source

Companies

  • CTSO
    Cytosorbents Corporation
    Health Care

Recent analyst ratings

  • Sep 7UpdateB. Riley Securities$4.00
  • Oct 14UpdateB. Riley Securities$10.00

Related

  • SEC8d
    Amendment: SEC Form 10-K/A filed by Cytosorbents Corporation
  • SEC22d
    Cytosorbents Corporation filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
  • SEC25d
    SEC Form 10-K filed by Cytosorbents Corporation
  • SEC29d
    Cytosorbents Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
  • PR29d
    CytoSorbents Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
  • PR35d
    CytoSorbents Announces HotSwap™ Launch, Renewed Aferetica Partnership, and New Clinical Evidence at ISICEM 2026
  • PR50d
    CytoSorbents to Report Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
  • SEC69d
    Amendment: SEC Form SCHEDULE 13G/A filed by Cytosorbents Corporation
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022